Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-02-001162
Filing Date
2002-06-14
Accepted
2002-06-13 21:20:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (ORBIMED ADVISORS INC.) sc13g_061202.txt SC 13G 9588
3 JOINT FILING AGREEMENT ex1_1tosc13g-061202.txt EX-1.1 1925
4 STATEMENT OF CONTROL PERSON ex2_1tosc13g-061202.txt EX-2.1 791
  Complete submission text file 0000947871-02-001162.txt   14457
Mailing Address CN 5350 PRINCETON NJ 08543-5350
Business Address CN 5350 PRINCETON NJ 08543-5350 6094523600
PHARMACOPEIA INC (Subject) CIK: 0001002388 (see all company filings)

EIN.: 330557266 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44599 | Film No.: 02678719
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)